awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38233353-3B8EE6B5-7E97-4175-8DD3-0D98FD1ACC9D
Q38233353-3B8EE6B5-7E97-4175-8DD3-0D98FD1ACC9D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38233353-3B8EE6B5-7E97-4175-8DD3-0D98FD1ACC9D
Evaluating surrogacy metrics and investigating approval decisions of progression-free survival (PFS) in metastatic renal cell cancer: a systematic review.
P2860
Q38233353-3B8EE6B5-7E97-4175-8DD3-0D98FD1ACC9D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38233353-3B8EE6B5-7E97-4175-8DD3-0D98FD1ACC9D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7a8220257ef5ba261cd61b2590f7d485d90c145b
P2860
FDA drug approval summary: bevacizumab plus interferon for advanced renal cell carcinoma.